Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction (2023)
- Authors:
- USP affiliated authors: NICOLAU, JOSÉ CARLOS - FM ; LIMA, FELIPE GALLEGO - FM ; PEREIRA, CESAR AUGUSTO CAPORRINO - FM ; BERTOLIN, ADRIADNE JUSTI - FM
- Unidade: FM
- DOI: 10.1002/ehf2.14201
- Subjects: SÍNDROME CORONARIANA AGUDA; INSUFICIÊNCIA CARDÍACA; MORTALIDADE
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2023
- Source:
- Título do periódico: Esc heart failure
- ISSN: 2055-5822
- Volume/Número/Paginação/Ano: v. 10, n. 1, p. 442-452, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
FURTADO, Remo Holanda de Mendonça et al. Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction. Esc heart failure, v. 10, n. 1, p. 442-452, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57358. Acesso em: 29 set. 2024. -
APA
Furtado, R. H. de M., Juliasz, M. G., Chiu, F. Y. J., Bastos, L. B. C., Dalçóquio, T. F., Lima, F. G., et al. (2023). Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction. Esc heart failure, 10( 1), 442-452. doi:10.1002/ehf2.14201 -
NLM
Furtado RH de M, Juliasz MG, Chiu FYJ, Bastos LBC, Dalçóquio TF, Lima FG, Melo RR, Pereira CAC, Bertolin AJ, Genestreti PRR, Nicolau JC. Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction [Internet]. Esc heart failure. 2023 ; 10( 1): 442-452.[citado 2024 set. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57358 -
Vancouver
Furtado RH de M, Juliasz MG, Chiu FYJ, Bastos LBC, Dalçóquio TF, Lima FG, Melo RR, Pereira CAC, Bertolin AJ, Genestreti PRR, Nicolau JC. Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction [Internet]. Esc heart failure. 2023 ; 10( 1): 442-452.[citado 2024 set. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57358 - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
Informações sobre o DOI: 10.1002/ehf2.14201 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
